Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5564 USD | +5.00% | -11.65% | +8.50% |
09/05 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
01/04 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.50% | 67M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.33% | 21.93B | |
-12.15% | 22.34B | |
-5.52% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Atara Plans to File Biologics License Application for Tabelecleucel in Q2 of 2024